Physician profile
Marshall S Pollack
NPI 1366472946
$888.08
in general payments reported to CMS, 2019-2025
21 companies · $163 in 2025
The $163 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $30.68 · 2021: $41.30 · 2022: $77.61 · 2023: $205 · 2024: $207 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $576.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $245.45 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $88.54 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $69.93 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $61.32 | 2021-2025 | |
| Celularity INC. | $50.00 | 2019 | |
| Evofem Biosciences, INC. | $41.65 | 2022-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $35.99 | 2022-2025 | |
| Baxter Healthcare | $34.99 | 2025 | Perclot |
| Organon LLC | $34.28 | 2023-2024 | Nexplanon |
| Lsi Solutions INC | $31.86 | 2024 | Cor-Knot |
| Therapeuticsmd, INC. | $28.98 | 2019 | |
| Millicent US INC | $26.92 | 2019-2020 | |
| Gilead Sciences, INC. | $19.00 | 2025 | |
| Coopersurgical, INC. | $18.55 | 2024 | Paragard T 380a |
| Shield Therapeutics INC | $17.39 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $16.20 | 2020 | |
| Exeltis, USA INC. | $15.15 | 2021 | |
| Agile Therapeutics, INC. | $13.91 | 2023 | Twirla |
| Alexion Pharmaceuticals, INC. | $13.00 | 2019 | |
| Avion Pharmaceuticals | $12.54 | 2021 | |
| Pfizer INC. | $12.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Pollack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.